SCHEMBL9526163

SCHEMBL9526163

CC(C)(C)OC(=O)NCC(Cl)c1ccc2ccccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.56
GABRB1 P18505 1/20 0.48
GABRB2 P47870 1/20 0.48
KDM4A O75164 1/20 0.46
ACACB O00763 1/20 0.46
CTSB P07858 1/20 0.46
CTSS P25774 1/20 0.46
CTSK P43235 1/20 0.46
CYP2D6 P10635 10/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
HIF1A Q16665 1/20 0.44
SLC6A2 P23975 10/20 0.43
SLC6A4 P31645 10/20 0.43
SLC6A3 Q01959 10/20 0.43
SYK P43405 1/20 0.43
NQO2 P16083 1/20 0.43
KCNH2 Q12809 8/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9525653 0.86 CYP2D6 (0.58) GABRB1GABRB2KDM4AACACBCTSB
SCHEMBL28136984 0.85 KDM4A (0.46) GABRB1GABRB2KDM4AACACBCTSB
SCHEMBL9525908 0.84 CTSK (0.51) ATMGABRB1GABRB2KDM4ACTSB
SCHEMBL28395771 0.84 CTSB (0.47) GABRB1GABRB2KDM4AACACBCTSB
SCHEMBL4367316 0.84 CTSB (0.47) GABRB1GABRB2KDM4AACACBCTSB
SCHEMBL6167126 0.82 KDM4A (0.44) GABRB1GABRB2KDM4AACACBCTSB
SCHEMBL6575223 0.81 CTSS (0.46) GABRB1GABRB2KDM4AACACBCTSB
SCHEMBL27463840 0.81 CTSB (0.46) ATMGABRB1GABRB2KDM4AACACB
SCHEMBL6165666 0.79 CTSS (0.44) ATMGABRB1GABRB2KDM4AACACB
SCHEMBL6824576 0.78 MTNR1A (0.49) GABRB1GABRB2KDM4AACACBCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365045-B1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1993-12-01 EP disclosed
EP-0365045-A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1990-04-25 EP disclosed
US-4699905-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1987-10-13 US disclosed
EP-0161801-A2 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1985-11-21 EP disclosed